↓ Skip to main content

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®

Overview of attention for article published in Trials, October 2021
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®
Published in
Trials, October 2021
DOI 10.1186/s13063-021-05664-0
Pubmed ID
Authors

Benjamin Speich, Frédérique Chammartin, Daniel Smith, Marcel P. Stoeckle, Patrizia Amico, Anna L. Eichenberger, Barbara Hasse, Macé M. Schuurmans, Thomas Müller, Michael Tamm, Michael Dickenmann, Irene A. Abela, Alexandra Trkola, Hans H. Hirsch, Oriol Manuel, Matthias Cavassini, Lars G. Hemkens, Matthias Briel, Nicolas J. Mueller, Andri Rauch, Huldrych F. Günthard, Michael T. Koller, Heiner C. Bucher, Katharina Kusejko

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 17%
Student > Master 8 12%
Researcher 6 9%
Student > Postgraduate 4 6%
Student > Ph. D. Student 4 6%
Other 6 9%
Unknown 27 41%
Readers by discipline Count As %
Medicine and Dentistry 13 20%
Nursing and Health Professions 8 12%
Social Sciences 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Economics, Econometrics and Finance 2 3%
Other 8 12%
Unknown 28 42%